posted on 2023-03-31, 15:42authored byCharles D. Blanke
Related Articles from Biomarkers in GIST: Partly Ready for Prime-Time Use
History
ARTICLE ABSTRACT
Gastrointestinal stromal tumors, or GISTs, are now among the most treatable of solid malignancies. Assessing actual tumor response remains challenging; however, in this issue of Clinical Cancer Research, two articles discuss biomarkers potentially helpful in predicting response or other long-term benefits with standard tyrosine kinase therapy use. (Clin Cancer Res 2009;15(18):5603–5)
